Literature DB >> 33945013

Theoretical studies on the mechanism of Pd2+-catalyzed regioselective C-H alkylation of indole with MesICH2CF3OTf.

Yao Shi1, Hongsheng Ma1, Jiaxuan Shao1, Chao Deng2.   

Abstract

The reaction mechanism of Pd2+-catalyzed regioselective C-H alkylation of indole with MesICH2CF3OTf has been investigated by the density functional theory calculations. The reaction mechanism mainly contains four steps: C-H activation, oxidative addition, reductive elimination, and ligands substitution. From our calculations, we find that the C-H activation step was realized by the acetate anion (-OAc) assisted concerted metalation deprotonation (CMD) process and the transition state of C-H activation process is a square planar configuration. Moreover, the calculation results suggest that the regioselectivity of C-H bond alkylation of indole with MesICH2CF3OTf can be ascribed to the different stability of the CMD transition states in C-H activation step and the relative stabilities of deprotonated intermediates.

Entities:  

Keywords:  C4-H selectivity; DFT studies; Indole; Pd2+-catalyst; Reaction mechanism

Year:  2021        PMID: 33945013     DOI: 10.1007/s00894-021-04773-6

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  28 in total

Review 1.  Advances in marine natural products of the indole and annelated indole series: chemical and biological aspects.

Authors:  U Pindur; T Lemster
Journal:  Curr Med Chem       Date:  2001-11       Impact factor: 4.530

Review 2.  Practical methodologies for the synthesis of indoles.

Authors:  Guy R Humphrey; Jeffrey T Kuethe
Journal:  Chem Rev       Date:  2006-07       Impact factor: 60.622

3.  Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.

Authors:  Adrian Hall; Andy Billinton; Susan H Brown; Anita Chowdhury; Gerard M P Giblin; Paul Goldsmith; David N Hurst; Alan Naylor; Sadhana Patel; Tiziana Scoccitti; Pamela J Theobald
Journal:  Bioorg Med Chem Lett       Date:  2008-03-10       Impact factor: 2.823

4.  Electronic Nature of Ketone Directing Group as a Key To Control C-2 vs C-4 Alkenylation of Indoles.

Authors:  Veeranjaneyulu Lanke; Kiran R Bettadapur; Kandikere Ramaiah Prabhu
Journal:  Org Lett       Date:  2016-10-13       Impact factor: 6.005

Review 5.  Marine indole alkaloids: potential new drug leads for the control of depression and anxiety.

Authors:  Anna J Kochanowska-Karamyan; Mark T Hamann
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

Review 6.  Indole alkaloids in medicine.

Authors:  Y Ban; Y Murakami; Y Iwasawa; M Tsuchiya; N Takano
Journal:  Med Res Rev       Date:  1988 Apr-Jun       Impact factor: 12.944

Review 7.  Current progress in the chemistry and pharmacology of akuammiline alkaloids.

Authors:  Antonio Ramírez; Silvina García-Rubio
Journal:  Curr Med Chem       Date:  2003-09       Impact factor: 4.530

8.  6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.

Authors:  P Stjernlöf; T Elebring; J Nilsson; B Andersson; S Lagerkvist; K Svensson; A Ekman; A Carlsson; H Wikström
Journal:  J Med Chem       Date:  1994-09-30       Impact factor: 7.446

9.  Direct olefination at the C-4 position of tryptophan via C-H activation: application to biomimetic synthesis of clavicipitic acid.

Authors:  Qiang Liu; Qingjiang Li; Yongfan Ma; Yanxing Jia
Journal:  Org Lett       Date:  2013-08-09       Impact factor: 6.005

10.  Palladium- and copper-catalyzed arylation of carbon-hydrogen bonds.

Authors:  Olafs Daugulis; Hien-Quang Do; Dmitry Shabashov
Journal:  Acc Chem Res       Date:  2009-08-18       Impact factor: 22.384

View more
  1 in total

Review 1.  Recent advances in theoretical studies on transition-metal-catalyzed regioselective C-H functionalization of indoles.

Authors:  Hongsheng Ma; Tongyan Yu; Longxiao Chi; Cong Huang; Xuwen Li; Rui Zhang; Chao Deng
Journal:  J Mol Model       Date:  2022-08-22       Impact factor: 2.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.